Changing the face of hepatitis C management - the design and development of sofosbuvir - Wikidata - wikimedia - TriplyDB

Changing the face of hepatitis C management - the design and development of sofosbuvir

Changing the face of hepatitis C management - the design and development of sofosbuvir

http://www.wikidata.org/entity/Q27011203

about

HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy Hepatitis C virus infection: Are there still specific problems with genotype 3?New-Onset Diabetes Mellitus With Exposure to Ledipasvir and Sofosbuvir Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.Continuum of hepatitis C care in France: A 20-year cohort study.Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.Nucleobase but not Sugar Fidelity is Maintained in the Sabin I RNA-Dependent RNA Polymerase.New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review.Impact of sustained virologic response on chronic kidney disease progression in hepatitis C.Hepatitis C and renal transplantation in era of new antiviral agents

P2860

Q26782405-E4607A0C-53DD-43B5-86BE-756D4D6283E0 Q36269670-6E5264D8-7033-4EBF-ADA9-B2474FD93196 Q38703743-5F0CACC7-27E2-4008-80FF-3BA8A683D8E5 Q38786027-55144FB8-E32B-4F0B-B961-5AC105656053 Q40066639-14CEA990-4751-44DD-A568-C7583EC1223E Q40712261-246E0AC2-C8F3-47B4-AC9C-8E92F35FF7CA Q41169102-2CA4E993-3781-43BE-9CE4-972447DF7879 Q47296036-92F97EB5-8F60-482A-9CCE-7E989D4E5CC2 Q47550115-97881220-C8C4-4A35-A76A-8C5BD63E8622 Q58792851-2B270131-50C2-455C-AE9E-906495FB7F3C

P2860

Changing the face of hepatitis C management - the design and development of sofosbuvir

http://www.wikidata.org/entity/Q27011203

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Changing the face of hepatitis C management - the design and development of sofosbuvir

@ast

Changing the face of hepatitis C management - the design and development of sofosbuvir

@en

Changing the face of hepatitis C management - the design and development of sofosbuvir

@nl

type

label

Changing the face of hepatitis C management - the design and development of sofosbuvir

@ast

Changing the face of hepatitis C management - the design and development of sofosbuvir

@en

Changing the face of hepatitis C management - the design and development of sofosbuvir

@nl

prefLabel

Changing the face of hepatitis C management - the design and development of sofosbuvir

@ast

Changing the face of hepatitis C management - the design and development of sofosbuvir

@en

Changing the face of hepatitis C management - the design and development of sofosbuvir

@nl

P1433

Q27011203-2720E28B-FB2C-426B-BD9D-9284064E65AC

P1476

Q27011203-B29FCE79-0892-4C80-BC0E-DE2A88E2C257

P2093

Q27011203-5CDBD4FF-BEFE-44BC-8AA2-B21A711F7A02

Q27011203-8C0251B1-B926-4A4E-BBB7-F6AEC30F0C95

Q27011203-B1E4C029-8DBF-47AE-8E9A-A23159F9FCC1

P275

Q27011203-40122DC6-D2F0-4E52-B47F-5A8189FF39AB

P2860

Q27011203-01C9CBB9-6CB4-4F7B-9F95-B74EA432053A

Q27011203-029CFB1A-125D-4E63-A780-AA9897C174A7

Q27011203-06C43EFF-CB49-4750-9FA4-83ADFA3AF536

Q27011203-091630A0-BB9B-4584-8433-AA7A8B322EE7

Q27011203-1556C515-FBEF-481F-A6FF-8A255B95B7BE

Q27011203-3156C974-08F3-4856-BA1F-D1B13A8BC7B2

Q27011203-3E354DD6-F9C0-4DD3-B4CB-01C56FBC0D83

Q27011203-47BF0AC2-6F30-4030-80A4-21D61F6954B4

Q27011203-56A33BFA-8EE9-40CE-B1D0-E24EF70DC6BF

Q27011203-589DEC83-84BF-4549-8F46-D7E574CF727D

P304

Q27011203-C4CC18BD-96FB-4CF4-B7DB-E8F28E45E24C

P31

Q27011203-CA3B26AA-0776-4B01-BA4D-CC3103169A3D

Q27011203-EC32FD41-30B2-43A4-B7E9-CC4524145A94

P356

Q27011203-A134B2BB-6834-471C-A1FB-9001D0119271

P407

Q27011203-43A4E72A-05C4-4C3A-B577-370A074771D9

P478

Q27011203-2254110B-0C48-4712-9861-9AE869537B07

P5008

Q27011203-F6227731-0992-4DA0-B0D0-85BDEE29DBE4

P577

Q27011203-39FE9824-B4AE-47B2-9ADB-4A64D554D4D7

Q27011203-99F7BA48-FE45-4AC4-875F-468872596CED

P5875

Q27011203-30DAD32A-F4CB-49E8-8583-F280A89591D2

P698

Q27011203-408CEC2F-F964-4927-A6EA-60C19BE7BE3B

P921

Q27011203-3C6BDDC9-FCA8-49F1-BFE7-8006547CF8E1

Q27011203-9A0FC133-B598-4C5A-8003-2855620AADE5

Q27011203-BEB3F132-6B14-49A8-B992-F60704D9C2E2

Q27011203-F970FEFA-5F2B-42B8-954F-86A3E858A324

P932

Q27011203-8D0421FE-15FE-4D57-A731-34D3D6A7049F

P356

P1433

Drug Design, Development and Therapy

P1476

Changing the face of hepatitis C management - the design and development of sofosbuvir

@en

P2093

Andrew Delemos

http://www.w3.org/2001/XMLSchema#string

Bennett Noell

http://www.w3.org/2001/XMLSchema#string

Siddesh Besur

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977

The Mechanism of Action of -D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine Involves a Second Metabolic Pathway Leading to -D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine 5'-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

P304

2367-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S65255

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276132990

http://www.w3.org/2001/XMLSchema#string

P698

25987834

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

4422286

http://www.w3.org/2001/XMLSchema#string